Remove 2008 Remove Communication Remove FDA
article thumbnail

Show 1337: Pros and Cons of LASIK Eye Surgery

The People's Pharmacy

FDA Considers New Warnings on LASIK Eye Surgery: The FDA first approved the laser devices for this procedure in 1999. Consequently, he petitioned the FDA to issue a Public Health Advisory regarding LASIK-related injuries. The FDA understands LASIK is safe and effective for those who are good candidates.

FDA 81
article thumbnail

Telemedicine and the Prescribing of Controlled Substances After the End of The Covid-19 Pandemic Emergency: DEA Announces Two Significant Proposed Rules: Read the Summary Below, But Learn All the Details and More at HPM’s Webinar on March 23, 2023 (Details Forthcoming….)

The FDA Law Blog

Palmer — The 2008 Ryan Haight Online Pharmacy Consumer Protection Act placed strict limits on online prescribing or the use of telemedicine encounters to prescribe controlled substances. The only schedule III-V narcotic drug that is currently approved by the FDA for OUD treatment is buprenorphine. By Karla L. 21 U.S.C. § 21 U.S.C. §

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

PharmDs – Crucial to Chronic Care Management Services: A Doctor’s Perspective

PharmD Live

According to the FDA, there are over 20,000 medications approved. A survey cited 1 by HealthIT.gov says with sources dating 2008-2012 and reviewed in 2019 says: 94% of providers report that their EHR makes records readily available at the point of care. Adverse drug events are avoided.

article thumbnail

What’s next for Container Closure Integrity Testing?

Pharmaceutical Technology

In the first official regulatory guidance on this matter released in 2008, the Food and Drug Administration (FDA) established CCIT as a requirement, closely tying it to the concept of microbiological integrity. In the same year, the European Commission published guidance relating to the manufacture of sterile medicinal products.

article thumbnail

2022 ISPE Aseptic Conference: Regulatory Panel Discusses ATMPs, Data Integrity, Inspections, & More

ISPE

FDA/CBER/OMPT/OCBQ. FDA/CBER/OMPT/OCBQ. Director, Office of Pharmaceutical Quality Operations. 2022 PIC/S Chair, Sr. Corporate Regulatory Compliance & Enforcement Advisor. Regulatory Operations and Enforcement Branch (ROEB), Health Canada. Rick Friedman. Deputy Director, Office of Manufacturing Quality. Brooke Higgins. Jörg Zimmermann.

FDA 52
article thumbnail

Citalopram interactions to avoid

The Checkup by Singlecare

These communication efforts can make all the difference. Likewise, if you are considering taking a new OTC product or are prescribed a new medicine by a specialist, check in with your primary care provider to ensure no interaction exists.

article thumbnail

A Proposal for a Comprehensive Quality Overall Summary

ISPE

Published June 2008. As part of the US Food and Drug Administration (FDA) QbD pilot 4 in 2005–2006, the need to convey how the control strategy is linked to the target product profile (TPP) and quality target product profile (QTPP) was discussed. Direct feedback from the US FDA on this pilot is shared in the discussion.